ClinVar Miner

Variants studied for Walker-Warburg congenital muscular dystrophy

Coded as:
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
185 53 627 685 30 1574

Gene and significance breakdown #

Total genes and gene combinations: 10
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign total
FKRP 111 27 333 377 13 861
FKTN 70 24 286 308 17 699
FKTN, TAL2, TMEM38B 2 0 1 0 0 3
LARGE1 0 0 3 0 0 3
CELSR1 0 0 2 0 0 2
POMT1 1 1 0 0 0 2
ABCA1, FKTN, FSD1L, SLC44A1, TAL2, TMEM38B 0 0 1 0 0 1
CALM3, DACT3, FKRP, GNG8, PRKD2, PTGIR, STRN4 0 0 1 0 0 1
FKTN, FSD1L, LOC130002286, LOC130002287 1 0 0 0 0 1
RXYLT1 0 1 0 0 0 1

Submitter and significance breakdown #

Total submitters: 6
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign total
Invitae 183 49 617 685 28 1562
Natera, Inc. 5 2 86 7 9 109
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine 1 2 0 0 0 3
Illumina Laboratory Services, Illumina 0 0 3 0 0 3
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard 0 0 2 0 0 2
Reproductive Health Research and Development, BGI Genomics 1 0 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.